Trademark: 77739920
Word
MACI
Status
Dead
Status Code
606
Status Date
Monday, January 30, 2012
Serial Number
77739920
Mark Type
4000
Filing Date
Tuesday, May 19, 2009
Published for Opposition
Tuesday, October 6, 2009
Abandoned Date
Monday, January 30, 2012

Trademark Owner History
GENZYME CORPORATION - Owner At Publication

Classifications
5 Pharmaceutical preparation for the treatment of articular cartilage disease
10 surgical orthopedic instruments, namely, biopsy instruments and arthroscopy instruments for autologous cartilage repair

Trademark Events
Jan 30, 2012
Abandonment Notice Mailed - No Use Statement Filed
Jan 30, 2012
Abandonment - No Use Statement Filed
Jun 11, 2011
Notice Of Approval Of Extension Request E-Mailed
Jun 9, 2011
Extension 3 Granted
Jun 9, 2011
Extension 3 Filed
Jun 9, 2011
Teas Extension Received
Feb 26, 2011
Notice Of Approval Of Extension Request E-Mailed
Feb 25, 2011
Extension 2 Granted
Dec 29, 2010
Extension 2 Filed
Feb 25, 2011
Case Assigned To Intent To Use Paralegal
Feb 4, 2011
Extension Received With Teas Petition
Feb 4, 2011
Petition To Revive-Granted
Feb 4, 2011
Teas Petition To Revive Received
Jan 31, 2011
Abandonment Notice Mailed - No Use Statement Filed
Jan 31, 2011
Abandonment - No Use Statement Filed
May 25, 2010
Notice Of Approval Of Extension Request E-Mailed
May 21, 2010
Extension 1 Granted
May 21, 2010
Extension 1 Filed
May 21, 2010
Teas Extension Received
Dec 29, 2009
Noa Mailed - Sou Required From Applicant
Oct 6, 2009
Official Gazette Publication Confirmation E-Mailed
Oct 6, 2009
Published For Opposition
Aug 28, 2009
Law Office Publication Review Completed
Aug 28, 2009
Assigned To Lie
Aug 25, 2009
Approved For Pub - Principal Register
Aug 25, 2009
Examiner's Amendment Entered
Aug 25, 2009
Notification Of Examiners Amendment E-Mailed
Aug 25, 2009
Examiners Amendment E-Mailed
Aug 25, 2009
Examiners Amendment -Written
Aug 18, 2009
Assigned To Examiner
May 22, 2009
New Application Office Supplied Data Entered In Tram
May 22, 2009
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24